Burning Rock Biotech (BNR) Return on Capital Employed: 2021-2024
- Burning Rock Biotech's Return on Capital Employed fell 280.00% to -2.69% in Q4 2024 from the same period last year, while for Dec 2024 it was -2.69%, marking a year-over-year decrease of 280.00%. This contributed to the annual value of -0.50% for FY2024, which is 12.00% up from last year.
- As of Q4 2024, Burning Rock Biotech's Return on Capital Employed stood at -2.69%, which was down 2,597.67% from 0.11% recorded in Q4 2023.
- Burning Rock Biotech's 5-year Return on Capital Employed high stood at 0.33% for Q4 2022, and its period low was -2.69% during Q4 2024.
- For the 3-year period, Burning Rock Biotech's Return on Capital Employed averaged around -0.71%, with its median value being -0.24% (2022).
- Per our database at Business Quant, Burning Rock Biotech's Return on Capital Employed skyrocketed by 74bps in 2022 and then crashed by 280bps in 2024.
- Over the past 4 years, Burning Rock Biotech's Return on Capital Employed (Quarterly) stood at -0.41% in 2021, then surged by 74bps to 0.33% in 2022, then dropped by 23bps to 0.11% in 2023, then tumbled by 280bps to -2.69% in 2024.
- Its Return on Capital Employed was -2.69% in Q4 2024, compared to 0.11% in Q4 2023 and 0.33% in Q4 2022.
